scispace - formally typeset
M

Mark A. Rubin

Researcher at University of Bern

Publications -  739
Citations -  109772

Mark A. Rubin is an academic researcher from University of Bern. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 145, co-authored 699 publications receiving 95640 citations. Previous affiliations of Mark A. Rubin include Henry Ford Health System & June.

Papers
More filters
Journal ArticleDOI

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

TL;DR: In this article, the authors used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression and identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1.
Journal ArticleDOI

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim, +86 more
- 18 Feb 2010 - 
TL;DR: It is demonstrated that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival, and a large majority of SCNAs identified in individual cancer types are present in several cancer types.
Journal ArticleDOI

Integrative clinical genomics of advanced prostate cancer

Dan R. Robinson, +89 more
- 21 May 2015 - 
TL;DR: This cohort study provides clinically actionable information that could impact treatment decisions for affected individuals and identified new genomic alterations in PIK3CA/B, R-spondin, BRAF/RAF1, APC, β-catenin, and ZBTB16/PLZF.
Journal ArticleDOI

The polycomb group protein EZH2 is involved in progression of prostate cancer

TL;DR: Dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.
Journal ArticleDOI

Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton, +291 more
- 28 Aug 2013 - 
TL;DR: Remodelling cellular metabolism constitutes a recurrent pattern in ccRCC that correlates with tumour stage and severity and offers new views on the opportunities for disease treatment.